559 related articles for article (PubMed ID: 26500057)
21. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.
Ho C; Wang C; Mattu S; Destefanis G; Ladu S; Delogu S; Armbruster J; Fan L; Lee SA; Jiang L; Dombrowski F; Evert M; Chen X; Calvisi DF
Hepatology; 2012 Mar; 55(3):833-45. PubMed ID: 21993994
[TBL] [Abstract][Full Text] [Related]
22. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
23. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
[TBL] [Abstract][Full Text] [Related]
24. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.
Zheng WW; Zhou J; Zhang CH; Liu XS
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2541-50. PubMed ID: 27383303
[TBL] [Abstract][Full Text] [Related]
26. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
[TBL] [Abstract][Full Text] [Related]
27. XTP8 promotes hepatocellular carcinoma growth by forming a positive feedback loop with FOXM1 oncogene.
Han M; Lu H; Han K; Yuan X; Liu S; Wang Y; Zhao J; Liang P; Cheng J
Biochem Biophys Res Commun; 2019 Jul; 515(3):455-461. PubMed ID: 31164201
[TBL] [Abstract][Full Text] [Related]
28. A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma.
Song BN; Chu IS
Exp Mol Med; 2018 Jan; 50(1):e418. PubMed ID: 29303511
[TBL] [Abstract][Full Text] [Related]
29. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.
Yang YF; Pan YH; Cao Y; Fu J; Yang X; Zhang MF; Tian QH
Oncotarget; 2017 Jul; 8(29):47195-47205. PubMed ID: 28525379
[TBL] [Abstract][Full Text] [Related]
30. LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression.
Wei Y; Wang Z; Zong Y; Deng D; Chen P; Lu J
Biomed Pharmacother; 2020 May; 125():109890. PubMed ID: 32106369
[TBL] [Abstract][Full Text] [Related]
31. TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.
Park TJ; Kim JY; Oh SP; Kang SY; Kim BW; Wang HJ; Song KY; Kim HC; Lim IK
Hepatology; 2008 May; 47(5):1533-43. PubMed ID: 18393292
[TBL] [Abstract][Full Text] [Related]
32. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1.
Yu CP; Yu S; Shi L; Wang S; Li ZX; Wang YH; Sun CJ; Liang J
Mol Med Rep; 2017 Oct; 16(4):5181-5188. PubMed ID: 28849004
[TBL] [Abstract][Full Text] [Related]
33. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
[TBL] [Abstract][Full Text] [Related]
34. Prx I suppresses K-ras-driven lung tumorigenesis by opposing redox-sensitive ERK/cyclin D1 pathway.
Park YH; Kim SU; Lee BK; Kim HS; Song IS; Shin HJ; Han YH; Chang KT; Kim JM; Lee DS; Kim YH; Choi CM; Kim BY; Yu DY
Antioxid Redox Signal; 2013 Aug; 19(5):482-96. PubMed ID: 23186333
[TBL] [Abstract][Full Text] [Related]
35. Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1.
Cao X; Liu L; Yuan Q; Li X; Cui Y; Ren K; Zou C; Chen A; Xu C; Qiu Y; Quan M; Zhang J; Cao J; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):264. PubMed ID: 31208440
[TBL] [Abstract][Full Text] [Related]
36. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
Huang X; Qin J; Lu S
Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
[TBL] [Abstract][Full Text] [Related]
38. Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma.
Qu K; Xu X; Liu C; Wu Q; Wei J; Meng F; Zhou L; Wang Z; Lei L; Liu P
Cancer Lett; 2013 Apr; 331(1):105-14. PubMed ID: 23262037
[TBL] [Abstract][Full Text] [Related]
39. Comparison of liver oncogenic potential among human RAS isoforms.
Chung SI; Moon H; Ju HL; Kim DY; Cho KJ; Ribback S; Dombrowski F; Calvisi DF; Ro SW
Oncotarget; 2016 Feb; 7(6):7354-66. PubMed ID: 26799184
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
Geng D; Zhao W; Feng Y; Liu J
Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]